Compugen Ltd.

As of June 30, 2026, Compugen Ltd. carries a market capitalization of 60.69B, placing it among publicly traded companies globally. Its enterprise value stands at 24.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Compugen Ltd.'s next confirmed earnings release is scheduled for November 16, 2026.

As of June 30, 2026, Compugen Ltd. has 94.72M shares outstanding.

As of June 30, 2026, Compugen Ltd. trades at a trailing price-to-earnings ratio of 5.79. The price-to-sales ratio is 2.75, and the price-to-book ratio stands at 2.31.

As of June 30, 2026, Compugen Ltd. trades at an EV/EBITDA multiple of 2.72 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.11 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 2.72 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 24.45B versus a market cap of 60.69B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Compugen Ltd. maintains a current ratio of 5.72, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Compugen Ltd. posted a return on equity (ROE) of 50.64, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 41.73 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 28.74, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 48.55, useful for judging operating efficiency across full business cycles. The company generates approximately 293.43M in revenue per employee across its workforce of 74.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Compugen Ltd. recorded 15.41M in income tax expense. That works out to an effective tax rate of 0.15, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 10.45B, leaving 10.43B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Compugen Ltd.'s stock has gained approximately 11.10% over the past 52 weeks. The 50-day moving average sits at 722.88, while the 200-day moving average is 681.99.

Over the twelve months ended June 30, 2026, Compugen Ltd. generated 21.93B in revenue and converted that into 10.43B in net income, yielding earnings per share of 110.54. EBITDA reached 8.98B, while operating income came in at 8.98B.

As of June 30, 2026, Compugen Ltd. holds 37.14B in cash and equivalents against 896.00M in total debt, resulting in a net debt position of -3.05B. Total book value stands at 26.30B, with working capital of 31.65B providing operational flexibility.

Over the twelve months ended June 30, 2026, Compugen Ltd. posted a gross margin of 86.89, reflecting its pricing power and cost economics. The operating margin of 40.94 and net profit margin of 47.55 provide insight into operational efficiency.

As of June 30, 2026, Compugen Ltd. has an Altman Z-Score of -0.08, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.